Beyond market averages, investors seeking exceptional growth focus on the art of stock selection. The right picks can significantly contribute to the expansion of your wealth.
In the latest session, United Therapeutics Corp (NASDAQ: UTHR) closed at $281.95 down -5.25% from its previous closing price of $297.56. In other words, the price has decreased by -$5.25 from its previous closing price. On the day, 1.02 million shares were traded. UTHR stock price reached its highest trading level at $300.47 during the session, while it also had its lowest trading level at $280.345.
Ratios:
For a deeper understanding of United Therapeutics Corp’s stock, let’s take a closer look at its various ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 4.17 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 11.90. For the most recent quarter (mrq), Quick Ratio is recorded 6.94 and its Current Ratio is at 7.26. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Cantor Fitzgerald on June 02, 2025, initiated with a Overweight rating and assigned the stock a target price of $405.
BofA Securities Upgraded its Underperform to Neutral on April 21, 2025, while the target price for the stock was maintained at $314.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Jul 24 ’25 when MAHON PAUL A sold 11,000 shares for $304.11 per share. The transaction valued at 3,345,225 led to the insider holds 36,781 shares of the business.
PAUL MAHON bought 11,000 shares of UTHR for $3,345,224 on Jul 24 ’25. On Jul 10 ’25, another insider, MAHON PAUL A, who serves as the EVP & GENERAL COUNSEL of the company, sold 11,000 shares for $300.31 each. As a result, the insider received 3,303,394 and left with 36,781 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, UTHR now has a Market Capitalization of 12717806592 and an Enterprise Value of 9702844416. As of this moment, United’s Price-to-Earnings (P/E) ratio for their current fiscal year is 11.01, and their Forward P/E ratio for the next fiscal year is 9.72. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 2.46. For the stock, the TTM Price-to-Sale (P/S) ratio is 4.13 while its Price-to-Book (P/B) ratio in mrq is 1.78. Its current Enterprise Value per Revenue stands at 3.153 whereas that against EBITDA is 6.075.
Stock Price History:
The Beta on a monthly basis for UTHR is 0.58, which has changed by -0.13984561 over the last 52 weeks, in comparison to a change of 0.16821623 over the same period for the S&P500. Over the past 52 weeks, UTHR has reached a high of $417.82, while it has fallen to a 52-week low of $266.98. The 50-Day Moving Average of the stock is -5.93%, while the 200-Day Moving Average is calculated to be -15.03%.
Shares Statistics:
For the past three months, UTHR has traded an average of 539.93K shares per day and 462520 over the past ten days. A total of 45.22M shares are outstanding, with a floating share count of 43.96M. Insiders hold about 2.53% of the company’s shares, while institutions hold 99.03% stake in the company. Shares short for UTHR as of 1752537600 were 1600574 with a Short Ratio of 2.96, compared to 1749772800 on 1614964. Therefore, it implies a Short% of Shares Outstanding of 1600574 and a Short% of Float of 4.66.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
